OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients

OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients

1 tracks • 0 plays • 0 favorites

OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients

omonioboli

0:0010:58
Knowledge